Goldman Sachs Upgrades Genmab A/S (GMAB) to Buy

Goldman Sachs analyst Rajan Sharma upgraded Genmab A/S (NASDAQ: GMAB) from Neutral to Buy with a price target of $30.50 (from $24.50).

For an analyst ratings summary and ratings history on Genmab A/S click here. For more ratings news on Genmab A/S click here.

Shares of Genmab A/S closed at $27.06 yesterday.

You May Also Be Interested In

• UBS Upgrades Apollo Tyres (APTY:IN) to Buy
• Goldman Sachs Downgrades AAC Technologies Holdings Inc. (2018:HK) (AACAY) to Neutral
• Alibaba (9988:HK) (BABA) PT Raised to HK$188.70 at Macquarie